CY1105870T1 - Μια μεθοδος για την παρασκευη 7 αλφα-υδροξυ 3-αμινοϋποκαθισταμενες στepολες χρησιμοποιωντας ενδιαμεσα με απροστατευτη μια 7.αλφα.-υδροξυ ομαδα - Google Patents

Μια μεθοδος για την παρασκευη 7 αλφα-υδροξυ 3-αμινοϋποκαθισταμενες στepολες χρησιμοποιωντας ενδιαμεσα με απροστατευτη μια 7.αλφα.-υδροξυ ομαδα

Info

Publication number
CY1105870T1
CY1105870T1 CY20061101829T CY061101829T CY1105870T1 CY 1105870 T1 CY1105870 T1 CY 1105870T1 CY 20061101829 T CY20061101829 T CY 20061101829T CY 061101829 T CY061101829 T CY 061101829T CY 1105870 T1 CY1105870 T1 CY 1105870T1
Authority
CY
Cyprus
Prior art keywords
alpha
hydroxy
steples
preparing
amino substituted
Prior art date
Application number
CY20061101829T
Other languages
Greek (el)
English (en)
Inventor
William A. Kinney
Xuehai Zhang
Ronald Michalak
Original Assignee
Genaera Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaera Corporation filed Critical Genaera Corporation
Publication of CY1105870T1 publication Critical patent/CY1105870T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20061101829T 2000-04-12 2006-12-20 Μια μεθοδος για την παρασκευη 7 αλφα-υδροξυ 3-αμινοϋποκαθισταμενες στepολες χρησιμοποιωντας ενδιαμεσα με απροστατευτη μια 7.αλφα.-υδροξυ ομαδα CY1105870T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19664600P 2000-04-12 2000-04-12
PCT/US2001/012004 WO2001079255A1 (en) 2000-04-12 2001-04-12 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group

Publications (1)

Publication Number Publication Date
CY1105870T1 true CY1105870T1 (el) 2011-02-02

Family

ID=22726246

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101829T CY1105870T1 (el) 2000-04-12 2006-12-20 Μια μεθοδος για την παρασκευη 7 αλφα-υδροξυ 3-αμινοϋποκαθισταμενες στepολες χρησιμοποιωντας ενδιαμεσα με απροστατευτη μια 7.αλφα.-υδροξυ ομαδα

Country Status (12)

Country Link
US (2) US6933383B2 (cg-RX-API-DMAC10.html)
EP (1) EP1274718B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003531148A (cg-RX-API-DMAC10.html)
AT (1) ATE342912T1 (cg-RX-API-DMAC10.html)
AU (2) AU5342701A (cg-RX-API-DMAC10.html)
CA (1) CA2406847C (cg-RX-API-DMAC10.html)
CY (1) CY1105870T1 (cg-RX-API-DMAC10.html)
DE (1) DE60123939T2 (cg-RX-API-DMAC10.html)
DK (1) DK1274718T3 (cg-RX-API-DMAC10.html)
ES (1) ES2273831T3 (cg-RX-API-DMAC10.html)
PT (1) PT1274718E (cg-RX-API-DMAC10.html)
WO (1) WO2001079255A1 (cg-RX-API-DMAC10.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410959B1 (en) * 2000-07-13 2008-08-12 Genaera Corporation Therapeutic uses for aminosterol compounds
CN100509838C (zh) * 2004-03-31 2009-07-08 可乐丽股份有限公司 制备5α-孕烷衍生物的方法
CN100509839C (zh) * 2004-03-31 2009-07-08 可乐丽股份有限公司 制备5α-孕烷衍生物的方法
WO2005095434A1 (ja) * 2004-03-31 2005-10-13 Kuraray Co., Ltd. 5α-プレグナン誘導体の製造方法
CA2571421A1 (en) 2004-06-24 2006-01-05 Nicholas Valiante Compounds for immunopotentiation
US20070203106A1 (en) * 2005-03-31 2007-08-30 Kuraray Co., Ltd. Method for Producing 5Alpha-Pregnane Derivative
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
TW200808739A (en) 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
CA2985271A1 (en) * 2007-09-06 2009-03-12 Ohr Pharmaceutical, Inc. A method for treating diabetes
JP2011506560A (ja) 2007-12-20 2011-03-03 ノバルティス アーゲー Pi3キナーゼ阻害剤として用いられるチアゾール誘導体
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
US20110161139A1 (en) * 2009-12-31 2011-06-30 Accenture Global Services Gmbh Capability Accelerator
AR082418A1 (es) 2010-08-02 2012-12-05 Novartis Ag Formas cristalinas de 1-(4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il)-amida de 2-amida del acido (s)-pirrolidin-1,2-dicarboxilico
WO2012104776A1 (en) 2011-01-31 2012-08-09 Novartis Ag Novel heterocyclic derivatives
SG11201401716XA (en) 2011-10-28 2014-05-29 Novartis Ag Novel purine derivatives and their use in the treatment of disease
CN104349779A (zh) 2012-05-16 2015-02-11 诺华股份有限公司 Pi-3激酶抑制剂的剂量方案
DK3076969T3 (da) 2013-12-06 2021-11-22 Novartis Ag Doseringsregime for en alfa-isoform-selektiv phosphatidylinositol-3-kinase-hæmmer
CN108472289A (zh) 2015-11-02 2018-08-31 诺华股份有限公司 磷脂酰肌醇3-激酶抑制剂的给药方案
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
CN109575096B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备16a-羟基泼尼松龙产品的新方法
CN109734765B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种17a-脱羟醋酸泼尼松龙产品的制备方法
CN109734764B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种17a-脱羟醋酸泼尼松龙的制备方法
CN109651475B (zh) * 2019-01-20 2021-01-01 湖南科瑞生物制药股份有限公司 一种制备16a-羟基泼尼松龙的新方法
AU2021244786A1 (en) 2020-03-25 2022-11-03 Risen (Suzhou) Pharma Tech Co., Ltd. Stable heavy isotopes in amide functional groups and uses thereof
CN113621016B (zh) * 2021-09-06 2022-05-17 北京泛球生物科技有限公司 一种地屈孕酮关键中间体的合成方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016390A (en) 1960-06-30 1962-01-09 Searle & Co N-(substituted alkyl) amino-5alpha-androstan-17beta-ols
US3370070A (en) 1965-06-16 1968-02-20 Searle & Co [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones
GB1565351A (en) 1975-06-02 1980-04-16 Theramex Steroid aminoethers
US4220598A (en) 1977-11-14 1980-09-02 Abbott Laboratories Method and reagents for measuring the level of conjugated bile acids
US4550163A (en) 1979-02-05 1985-10-29 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates
US4301246A (en) * 1979-04-12 1981-11-17 Hoffmann-La Roche Inc. Process for chenodeoxycholic acid production
US4230625A (en) * 1979-04-12 1980-10-28 Hoffmann-La Roche Inc. Process for chenodeoxycholic acid and intermediates therefore
US4372888A (en) 1980-08-26 1983-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Nondenaturing zwitterionic detergents
JPS5842878B2 (ja) 1981-12-02 1983-09-22 名糖産業株式会社 12−オキソコラン酸トシルヒドラゾン化合物、その製法ならびに利用
DE3366932D1 (en) 1982-07-29 1986-11-20 Lehner Ag New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
US5001116A (en) 1982-12-20 1991-03-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US4994443A (en) 1982-12-20 1991-02-19 The Children's Medical Center Corporation Inhibition of angiogenesis
IT1221734B (it) 1983-02-24 1990-07-12 Schiena Michele Giuseppe Di Ursodesossicolico solfato acido sale sodico
US4545938A (en) 1983-11-02 1985-10-08 Beth Israel Medical Center Chemical synthesis
EP0243449A1 (en) 1985-10-18 1987-11-04 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US4771042A (en) 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
JPS62175497A (ja) 1986-01-28 1987-08-01 Wakunaga Pharmaceut Co Ltd 胆汁酸誘導体およびその製造法
US5075464A (en) 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
SE8702254D0 (sv) 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
IT1229569B (it) 1989-04-17 1991-09-04 Giuliani Spa Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1229570B (it) 1989-04-17 1991-09-04 Giuliani Spa Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
JPH07116215B2 (ja) 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
PT93847A (pt) 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US4966897A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5004737A (en) 1989-09-22 1991-04-02 Pacific Chemical Co., Ltd. Quaternary ammonium-substituted sterol derivatives
EP0466315A3 (en) 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
CA2081205C (en) 1990-06-11 2001-02-27 John W. Wilks Steroids which inhibit angiogenesis
US5250524A (en) 1990-12-06 1993-10-05 Hoechst Aktiengesellschaft Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
US5192756A (en) 1992-03-18 1993-03-09 The Children's Hospital Of Pennsylvania Aminosterol antibiotic
AU4534593A (en) 1992-06-12 1994-01-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5247104A (en) 1992-11-04 1993-09-21 Wisconsin Alumni Research Foundation Preparation of 1α, 24-dihydroxyvitamin D analogs
JPH06329679A (ja) 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
AU6392894A (en) 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Chemical synthesis of squalamine
CA2157594A1 (en) 1993-03-10 1994-09-15 Leah L. Frye Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants
WO1994024800A1 (en) 1993-04-12 1994-10-27 Unisys Corporation Portable adapter for portable pc
DK0749437T3 (da) 1994-03-10 2002-03-04 Magainin Pharma Farmaceutisk anvendelse af steroidderivater
US5792635A (en) 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
AU723663C (en) 1995-06-07 2001-11-01 Magainin Pharmaceuticals, Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds
US6262283B1 (en) * 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds

Also Published As

Publication number Publication date
AU2001253427B2 (en) 2007-02-08
EP1274718B1 (en) 2006-10-18
US6933383B2 (en) 2005-08-23
JP2003531148A (ja) 2003-10-21
WO2001079255A1 (en) 2001-10-25
US20030171576A1 (en) 2003-09-11
DE60123939T2 (de) 2007-05-31
AU5342701A (en) 2001-10-30
US7728157B2 (en) 2010-06-01
ES2273831T3 (es) 2007-05-16
PT1274718E (pt) 2007-01-31
DE60123939D1 (de) 2006-11-30
ATE342912T1 (de) 2006-11-15
US20050187202A1 (en) 2005-08-25
CA2406847A1 (en) 2001-10-25
DK1274718T3 (da) 2007-02-12
CA2406847C (en) 2009-11-17
EP1274718A1 (en) 2003-01-15

Similar Documents

Publication Publication Date Title
HUP0102843A2 (hu) Eljárás (3-izoxazolinil)-acil-benzolok előállítására
TR199900228T2 (xx) �kameli/katk�l� pirido-veya pirimido-i�eren 6,6-veya 6,7-bisiklik t�revler.
DK0789578T3 (da) Inhibitorer af multikatalytisk protease
FR2733244B1 (fr) Systeme de stabilisants a base de derives de polyalkylpiperidine
DK1274718T3 (da) En fremgangsmåde til forberedelse af 7.alpha.-hydroxy 3-aminosubstituerede steroler vee en ubeskyttet 7.alpha.-hydroxy gruppe
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
DE69402043D1 (de) Verfahrenshilfsmittel für gaserzeugende Zusammensetzungen
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
AR006390A1 (es) Derivados de lactama
ATE356813T1 (de) Anilidderivate, deren herstellung und verwendung
NO20002406D0 (no) FremgangsmÕte for selektiv oksidering av organiske forbindelser
DE69705180D1 (de) Herstellungsverfahren von keramischen Röhren für Metallhalogenidlampen
TR200000808T2 (tr) Triscyklik triyazolobenzazepin türevler, bunları üretme süreci ve anti alerjik.
EE9800394A (et) Ratseemilise ketamiini lahutamise meetod
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
ES2164881T3 (es) Derivados de 6-carboxamido dihidropirano.
EA200100040A1 (ru) Химический синтез морфолиновых производных
ATE277887T1 (de) Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion
DK0983237T3 (da) Kemisk fremgangsmåde til reduktion af 1-substituerede 3-hydroxymethyl-4-(4-fluorphenyl)tetrahydro-pyridiner
ATE353937T1 (de) Verfahren zur synthese einer oxonolverbindung
ID17048A (id) Alat untuk produksi besi spons
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
DK0975601T3 (da) Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor
MY139258A (en) Carbamoyl-type benzofuran derivatives
ATE328106T1 (de) Verfahren für die biotransformation von colchicon-verbindungen in die entsprechenden 3-glykosyl- derivate